A carregar...
Triple-negative breast cancer therapy: Current and future perspectives (Review)
Triple-negative breast cancer (TNBC) accounts for 10-15% of all breast cancer cases. TNBCs lack estrogen and progesterone receptors and express low levels of HER2, and therefore do not respond to hormonal or anti-HER2 therapies. TNBC is a particularly aggressive form of breast cancer that generally...
Na minha lista:
| Publicado no: | Int J Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7646583/ https://ncbi.nlm.nih.gov/pubmed/33174058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5135 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|